Vaccine Industry Retools Itself for Speed
Vaccine Manufacturing Moves toward Mass Customization
Toward a Universal Flu Vaccine
New Candidate Fights Back against the Flu’s Efforts to Undermine the Human Immune System
Seeking New Users for iSeq
The Changing Sequencing Landscape
Bioelectricity, New Peer Reviewed Journal Announced
An Outstanding and Influential Foundation for a Dynamic, Emerging Field
For full access to this article login to GEN Select now.
Biotech Embroiders Intricate Glycopatterns
Glycans Account for Some of the More Ornate Weavings from Nature's Post-Translational Loom
- Through its association with monoclonal antibody quality, safety, and efficacy, glycosylation remains a hot issue for biotech. Accordingly, improving glycosylation is a priority for companies such as Agilent Technologies, which has undertaken several initiatives to improve glycan analysis within the context of the company’s analytical systems. ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.